Dr Sanjay Juneja, medical oncologist and hematologist, and Chief of Oncology at Baton Rouge General Hospital–Mary Bird Perkins Cancer Center in Baton Rouge, LA, also known as “The Onc Doc,” is a well-known healthcare influencer. In the video above, Dr Juneja provides his perspectives on key efficacy and safety data from the EMERALD trial, the importance of testing for ESR1 mutations, and what the approval of ORSERDU (elacestrant) means for patients.
Sanjay Juneja, MD, on the Approval of ORSERDU™
Videos — September 6, 2023
Medical Oncologist and Hematologist | Chief of Oncology
Baton Rouge General Hospital–Mary Bird Perkins Cancer Center
Baton Rouge, LA
Baton Rouge General Hospital–Mary Bird Perkins Cancer Center
Baton Rouge, LA
